Catalog No.
DHC09698
Description
Trastuzumab deruxtecan is an ADC consisting of a HER2-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of HER2-positive breast cancer and gastric cancer.
Species reactivity
Human
Clonality
Monoclonal
Target
HER2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Purification
Purified by Ion Exchange Chromatography.
Applications
Research Grade Biosimilar
Form
Liquid
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
ENHERTU, DS-8201
Clone ID
Trastuzumab deruxtecan
For research use only. Not for human or drug use.
